DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read More

Top Stories

Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to

Today, we're witnessing an unprecedented convergence of...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
EU MedTech Summit 2020

EU MedTech Summit 2020: Highlights and Top 3 Takeaways

How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...
A fireside chat on how MedTech leaders are called to respond to EU-MDR

Fireside Chat Part 1: How MedTech Leaders Are Called to Respond to EU MDR

A fireside chat on how MedTech leaders are called to respond to EU-MDR...
The battle for evidence-based truth in a war of misinformation

The Battle for Evidence-Based Truth in a War of Misinformation

I was talking to someone I know — let’s call her Joanna — about the...

Learn more ABOUT our company.